Venus Medtech Hangzhou Inc (2500.HK)
Company Info
ISIN | CNE100003PJ8 |
---|---|
Sector | Healthcare |
Industry | Medical Devices |
Highlights
Market Cap | HK$2.48B |
---|---|
Revenue (TTM) | HK$452.11M |
Gross Profit (TTM) | HK$324.34M |
EBITDA (TTM) | -HK$694.36M |
Year Range | HK$3.74 - HK$12.78 |
Target Price | HK$9.28 |
Share Price Chart
Loading data...
Compare to other instruments
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in Venus Medtech Hangzhou Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Venus Medtech Hangzhou Inc had a return of 0.00% year-to-date (YTD) and -51.64% in the last 12 months.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 0.00% | 10.16% |
1 month | 0.00% | 3.47% |
6 months | 15.40% | 22.20% |
1 year | -51.64% | 30.45% |
5 years (annualized) | N/A | 13.16% |
10 years (annualized) | N/A | 10.89% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 0.00% | 0.00% | ||||||||||
2023 | -22.90% | -16.82% | -4.73% | 26.86% | 0.00% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
This table presents risk-adjusted performance metrics for Venus Medtech Hangzhou Inc (2500.HK) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
Venus Medtech Hangzhou Inc | -0.92 | ||||
S&P 500 | 2.79 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Venus Medtech Hangzhou Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Venus Medtech Hangzhou Inc was 95.95%, occurring on Oct 26, 2023. The portfolio has not yet recovered.
The current Venus Medtech Hangzhou Inc drawdown is 94.09%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-95.95% | Jan 26, 2021 | 677 | Oct 26, 2023 | — | — | — |
-30.95% | Oct 14, 2020 | 30 | Nov 25, 2020 | 41 | Jan 25, 2021 | 71 |
-26.84% | Jul 9, 2020 | 38 | Aug 31, 2020 | 24 | Oct 6, 2020 | 62 |
-24.61% | May 21, 2020 | 6 | May 28, 2020 | 14 | Jun 17, 2020 | 20 |
-17.96% | Feb 28, 2020 | 10 | Mar 12, 2020 | 18 | Apr 7, 2020 | 28 |
Volatility
Volatility Chart
The current Venus Medtech Hangzhou Inc volatility is 0.00%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |